![Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The](https://www.thelancet.com/cms/attachment/27116734-900d-4f93-906c-61d126ea039b/gr1_lrg.jpg)
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe - The
![A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy](https://www.cell.com/cms/attachment/71e0677c-57e3-4f48-8ebf-b42c74b8c848/fx1_lrg.jpg)
A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models: Molecular Therapy
![Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology](https://www.thelancet.com/cms/attachment/1b50e54c-826f-483e-99ae-7498698cfd92/gr1_lrg.jpg)
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors - The Lancet Oncology
![Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina - The Lancet Regional Health – Americas Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina - The Lancet Regional Health – Americas](https://www.thelancet.com/cms/asset/394c7d04-633c-4b1b-a67a-51279311d368/gr1.jpg)